← Open Payments lookup

ROBERT SHIH: Open Payments

NPI 1760589147 · HAVERHILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,353 in 210 payments from 33 companies in 2025. Trend: 2023 $4,475 · 2024 $4,798 · 2025 $4,353

Food & beverage: $4,334Education: $19
CompanyPaymentsAmount
ABBVIE INC.32$545
AstraZeneca Pharmaceuticals LP19$498
PFIZER INC.19$358
Boehringer Ingelheim Pharmaceuticals, Inc.13$257
Lilly USA, LLC11$248
Teva Pharmaceuticals USA, Inc.15$243
Otsuka America Pharmaceutical, Inc.11$216
Amgen Inc.5$200
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$199
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$197

Products named: REXULTI, JARDIANCE, UBRELVY, VRAYLAR, XIFAXAN, CAPLYTA, AIRSUPRA, FARXIGA.

Industry payments across MA — which companies pay providers there.